MIST Milestone Pharmaceuticals Inc: Accounting Value per Share

Graphic logo of Milestone Pharmaceuticals (MIST)

The market value dynamics of Milestone Pharmaceuticals (MIST), whose business relies on unique tachycardia suppression patents and support from the US medical lobby, currently stands at 0.15. Intense competition with industry behemoths forces the company to fight for the speed of product implementation. Currently, the focus has shifted toward completing FDA regulatory reviews to facilitate the imminent market launch of an innovative spray.

Accounting Value of a Share: Milestone Pharmaceuticals, Inc. (MIST) for 07/04/2022 - 10/27/2026

milestonepharma.com - analytical breakdowns and key metrics (MIST)

- price and consensus price forecast:
Price Chart Milestone Pharma|MIST - Analyst Median Target
- market capitalization data:
Market Valuation Milestone Pharmaceuticals Inc.|MIST - Aggregate Business Value
- book capitalization data:
Book Value per Share Milestone Pharmaceuticals|MIST - Accounting Value of Company|Market Capitalization to Book Value Ratio milestonepharma.com|MIST - Company Assets
- debt and liquidity data:
Total Debt to Capital Milestone Pharmaceuticals|MIST - Long-Term Debt to Capital|Short-Term Debt to Equity Milestone Pharmaceuticals Inc.|MIST - Aggregate Debt Obligations|Debt to Book Value Milestone Pharmaceuticals Inc.
Initial company analysis:MIST (Milestone Pharma)
Manufactured products of Milestone Pharmaceuticals Inc.

The equity per share dynamics of Milestone Pharmaceuticals (MIST) reflect the efficiency of resource management required to ensure seamless and rapid logistics for emergency cardiology medications. This indicator is calculated as the ratio of net assets to the number of shares, demonstrating the actual book value of the business devoid of market speculation, which allows investors to assess the fundamental backing of each share.

Competitor analysis for Milestone Pharmaceuticals

Net Assets per Single Share REGN (Regeneron Inc.)|iRhythm Corp (IRTC) - Net Assets per Share|LNTH - Accounting Value per Share|mineralystx.com (MLYS) - Book Price of a Share|HTFL - Book Value per Share|Accounting Value of a Share Kestra Medical Technologies, Inc.|Esperion Therapeutics Inc - Book Value per Share|Net Asset Value per Share Amarin Pharma (AMRN)|Book Value per Share AVR (Anteris Technologies)|Tenaya - Book Value per Share|Net Assets per Single Share CVRx (CVRX)|Cardiol Therapeutics (CRDL) - Accounting Value of a Share|BEAT - Accounting Value per Share|TENX (Tenax Therapeutics Inc) - Book Price of a Share|Net Assets per Single Share ADGM|Accounting Value per Share biocardia.com|VTAK (Catheter Precision, Inc.) - Book Value per Share|Net Assets per Share ABIO (arcabio.com)|Net Assets per Single Share Acasti Pharma Inc. ACST|Net Assets per Single Share Aerovate Therapeutics, Inc AVTE|VERV (Verve) - Book Value per Share|WINT: Net Asset Value per Share